R A Kerber1, M L Slattery. 1. Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, USA.
Abstract
OBJECTIVE: To estimate the relative risks and population attributable risks of ovarian cancer associated with family histories of cancer at several sites. METHODS: A matched case-control analytic study (662 cases, 2647 controls), employing the Utah Population Database, a genealogy of approximately 1 million individuals linked to cancer incidence data from the Utah Cancer Registry. Family history was assessed using kinship order and a kinship-weighted familial standardized incidence ratio statistic. RESULTS: Family histories of ovarian, uterine, breast, and pancreatic cancer were significantly associated with increased risk of ovarian cancer. The relative risk of ovarian cancer was 4.31 (95% confidence interval [CI], 2.35 to 7.90) for women with a first-degree relative with ovarian cancer, 2.12 (95% CI, 1.19 to 3.78) for women with an affected second-degree relative, and 1.48 (95% CI, 0.98 to 2.24) for women with an affected third-degree relative. The odds ratio (OR) was 2.06 (95% CI, 1.44 to 2.93) for those with the highest familial standardized incidence ratio. No age differences were observed between cases with and without a family history of ovarian cancer. There was substantial heterogeneity of family history effects by cell type. Increased parity was not protective among women with a strong family history of cancer at the sites studied (OR, 1.11; 95% CI, 0.38 to 3.26), although it was protective among women without a family history of these cancers (OR, 0.29; 95% CI, 0.11 to 0.62). CONCLUSIONS: The risk of ovarian cancer was substantially increased among women with family histories of ovarian, uterine, pancreatic, and, to a lesser degree, breast cancer. Among women with family histories of any of these cancers, the risk of ovarian cancer is not diminished by high parity.
OBJECTIVE: To estimate the relative risks and population attributable risks of ovarian cancer associated with family histories of cancer at several sites. METHODS: A matched case-control analytic study (662 cases, 2647 controls), employing the Utah Population Database, a genealogy of approximately 1 million individuals linked to cancer incidence data from the Utah Cancer Registry. Family history was assessed using kinship order and a kinship-weighted familial standardized incidence ratio statistic. RESULTS: Family histories of ovarian, uterine, breast, and pancreatic cancer were significantly associated with increased risk of ovarian cancer. The relative risk of ovarian cancer was 4.31 (95% confidence interval [CI], 2.35 to 7.90) for women with a first-degree relative with ovarian cancer, 2.12 (95% CI, 1.19 to 3.78) for women with an affected second-degree relative, and 1.48 (95% CI, 0.98 to 2.24) for women with an affected third-degree relative. The odds ratio (OR) was 2.06 (95% CI, 1.44 to 2.93) for those with the highest familial standardized incidence ratio. No age differences were observed between cases with and without a family history of ovarian cancer. There was substantial heterogeneity of family history effects by cell type. Increased parity was not protective among women with a strong family history of cancer at the sites studied (OR, 1.11; 95% CI, 0.38 to 3.26), although it was protective among women without a family history of these cancers (OR, 0.29; 95% CI, 0.11 to 0.62). CONCLUSIONS: The risk of ovarian cancer was substantially increased among women with family histories of ovarian, uterine, pancreatic, and, to a lesser degree, breast cancer. Among women with family histories of any of these cancers, the risk of ovarian cancer is not diminished by high parity.
Authors: Michele L Cote; Maryjean Schenk; Ann G Schwartz; Fawn D Vigneau; Margaret Kinnard; Joel K Greenson; Jon P Fryzek; Gui Shuang Ying; David H Garabrant Journal: J Gastrointest Cancer Date: 2007
Authors: B E Kiely; M L Friedlander; R L Milne; L Stanhope; P Russell; M A Jenkins; P Weideman; S A McLachlan; P Grant; J L Hopper; K A Phillips Journal: Fam Cancer Date: 2011-09 Impact factor: 2.375
Authors: Brenda Lauffart; Mary M Vaughan; Roger Eddy; David Chervinsky; Richard A DiCioccio; Jennifer D Black; Ivan H Still Journal: BMC Womens Health Date: 2005-05-26 Impact factor: 2.809
Authors: Richard A Kerber; Christopher I Amos; Beow Y Yeap; Dianne M Finkelstein; Duncan C Thomas Journal: BMC Med Genet Date: 2008-07-10 Impact factor: 2.103
Authors: Dolores Gallardo-Rincón; Rosa María Álvarez-Gómez; Edgar Montes-Servín; Alfredo Toledo-Leyva; Elizabeth Montes-Servín; David Michel-Tello; Gabriela Alamilla-García; Antonio Bahena-González; Elizabeth Hernández-Nava; Veronica Fragoso-Ontiveros; Raquel Espinosa-Romero; Lucely Cetina-Pérez Journal: Transl Oncol Date: 2019-12-20 Impact factor: 4.243